Provided are a boron compound-layered double hydroxide (LDH) nanohybrid in
which a boron compound for boron neutron capture therapy is intercalated
in between layers of LDH, a method of preparing the boron compound-LDH
nanohybrid, and a pharmaceutical composition including the boron
compound-LDH nanohybrid, which can be used in boron neutron capture
therapy.